American depositary receipts (ADRs) of Novo Nordisk (NVO) jumped over 4% in pre-market trading this morning after reporting a healthy sales ...

A softer-than-expected Producer Price Index (PPI) print boosted equity futures on ... inflation has become stuck uncomfortably above its target," write Wells Fargo economists Sarah House and ...

Bethenny Frankel, Spencer Pratt, and Alix Earle hosted a TikTok LIVE together ahead of the app's temporary shutdown. Earle ...

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

LLY is reporting earnings tomorrow and the options market predicts major moves. PFP system shows bullish positioning and ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

The Liberal government has spent years touting its efforts to make tech giants pay. Now, those pieces of legislation could be ...

Lilly said the U.S. could tackle that issue as part of the CUSMA review. Geist said another target could be Canada’s Online News Act, which compels tech companies to enter into agreements with news ...

On Friday, Guggenheim analysts revised their price target for Eli Lilly (NYSE:LLY) shares, reducing it to $973.00 from the previous $995.00, while reiterating a Buy rating on the stock.